- NSE
- LAURUSLABS
- BSE
- 540222
- ISIN
- INE947Q01028
LAURUS LABS
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹2,454.00
+₹114.00 (+4.87%)
NSE close ·
LAURUS LABS closed at ₹2,454.00 on 9 Nov 2026, up 4.87% on the day, and is up 149.86% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹930.20 to ₹2,454.00.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹1,32,593 Cr
- P/E (TTM)
- 99.0
- Industry P/E
- 35.5
- EPS (TTM)
- ₹24.78
- P/B
- 21.88
- Book value
- ₹112.17
- ROE
- 22.1%
- ROCE
- 22.5%
- Debt/equity
- 0.41
- Operating margin
- 24.1%
- Net margin
- 17.1%
- Dividend yield
- 0.09%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +21.64% | +13.76% |
| Net profit | +95.38% | +53.03% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹2,219 Cr | ₹436 Cr | +124.27% | ₹8.16 |
| Jun 2026 | ₹2,035 Cr | ₹362 Cr | +123.94% | ₹6.80 |
| Mar 2026 | ₹1,823 Cr | ₹282 Cr | +21.19% | ₹5.17 |
| Dec 2025 | ₹1,784 Cr | ₹252 Cr | +171.01% | ₹4.65 |
| Sep 2025 | ₹1,680 Cr | ₹194 Cr | +874.89% | ₹3.61 |
| Jun 2025 | ₹1,580 Cr | ₹162 Cr | +1,175.08% | ₹3.02 |
| Mar 2025 | ₹1,779 Cr | ₹233 Cr | +210.28% | ₹4.33 |
| Dec 2024 | ₹1,424 Cr | ₹92.94 Cr | +298.20% | ₹1.71 |
Armor risk check
LAURUS LABS moves about 2× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is LAURUS LABS's share price today?
LAURUS LABS (NSE: LAURUSLABS) closed at ₹2,454.00 on 9 Nov 2026, up 4.87% from the previous close of ₹2,340.00. It traded between ₹2,351.50 and ₹2,480.00 that day.
What are LAURUS LABS's 52-week high and low?
Over the last 52 weeks LAURUS LABS traded between ₹917.95 and ₹2,480.00, adjusted for splits and bonuses.
What are LAURUS LABS's NSE symbol, BSE code and ISIN?
LAURUS LABS has NSE symbol LAURUSLABS, BSE code 540222, ISIN INE947Q01028.
How has LAURUS LABS performed over 1, 3 and 5 years?
LAURUS LABS's share price return: 1Y +149.86%, 3Y +87.94% a year, 5Y +37.98% a year. Dividends are not included.
Does LAURUS LABS pay a dividend?
Yes. LAURUS LABS's latest dividend went ex on 6 Nov 2026: Interim · ₹1.00 per share. Dividends over the past year come to a yield of 0.09% at the latest close.
What is LAURUS LABS's P/E ratio?
LAURUS LABS's P/E ratio is 99.0: the ₹2,454.00 close on 9 Nov 2026 over trailing twelve-month EPS of ₹24.78 (consolidated, four quarters to 30 Sep 2026).
What is LAURUS LABS's market cap?
LAURUS LABS's market cap is ₹1,32,593 Cr at the close on 9 Nov 2026.
Which sector is LAURUS LABS in?
LAURUS LABS is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how LAURUS LABS fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app